ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), which represents 15–20% of breast cancers (BC), is classified based on the exclusion criteria of lack of estrogen and progesterone receptor expression and absence of human epidermal growth factor receptor 2 (HER2) overexpression.